Project Grant HT94252411076
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$682K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $571,350.00 in funding to the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, California. The award supports research aimed at developing metabolic interventions to halt the progression of pancreatic cancer. SBP, an independent non-profit biomedical research organization, will leverage advanced technologies and...
This federal Project Grant award of $195,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Sanford Burnham Prebys Medical Discovery Institute (SBP) to investigate the function and therapeutic potential of R loops in glioblastoma. The research project will be conducted over a 2-year period from August 1, 2025 to July 31, 2027. SBP, a non-profit biomedical research organization, has extensive experience conducting...
The federal Project Grant award of $974,355.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sanford Burnham Prebys Medical Discovery Institute. The award supports a research project entitled "WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY" with a performance period from July 1, 2024 to June 30, 2027. The funding will enable the Sanford Burnham Prebys Medical Discovery...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) provides $768,437.00 to the Sanford Burnham Prebys Medical Discovery Institute (SBP) to conduct research aimed at identifying chemical compounds that inhibit the chromatin reader SGF29, which has been identified as a regulator of oncogene transcription in acute myeloid leukemia (AML). The goal of the project is to implement high-throughput screening assays developed by SBP to discover...
The Sanford Burnham Prebys Medical Discovery Institute (SBPMDI) was awarded a $1.46 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will fund research to therapeutically target a lipid kinase regulator of mutant p53 in breast cancer. Through February 2021 to January 2024, SBPMDI researchers will investigate medical solutions for breast cancer by exploring the role of lipid signaling pathways...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
The federal Project Grant award, valued at $176,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the Sloan-Kettering Institute for Cancer Research in establishing a mouse model of myxoid/round cell liposarcoma with endogenous translocations. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on critical health...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
The federal Project Grant award, totaling $532,916, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives at the University of California, San Diego (UCSD) focused on "COMBINED EPIGENETIC REPROGRAMMING AND IMMUNOTHERAPY TO TACKLE HIGH-RISK MULTIPLE MYELOMA." The project aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
This federal Project Grant award, valued at $1,306,778.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will support a research project titled "IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA" conducted by the University of...